Celgene

YTD

ALL

Why Robinhood?

You can watch Celgene and buy or sell other stocks, ETFs, and their options commission-free!

About CELG

Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options. There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene.

CEO

Mark J. Alles

CEOMark J. Alles

Employees

—

Employees—

Headquarters

Summit, New Jersey

HeadquartersSummit, New Jersey

Founded

1986

Founded1986

Employees

—

Employees—

CELG Key Statistics

Market cap

77.04B

Market cap77.04B

Price-Earnings ratio

13.32

Price-Earnings ratio13.32

Dividend yield

—

Dividend yield—

Average volume

27.24M

Average volume27.24M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$110.70

52 Week high$110.70

52 Week low

$58.59

52 Week low$58.59